“fsa eligible”的搜索结果，显示 101-110 项，共有 2584 项

1. 血液科- 临床试验- 妙佑医疗国际

   Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...

2. 心血管医学- 临床试验- 妙佑医疗国际

   The purpose of this study is to assess the feasibility of using the current FDA-approved AliveCor Kardia device and their AliveCor Tripod device (FDA ...

3. 血液科- 临床试验- 妙佑医疗国际

   ... approved by the U.S. Food and Drug Administration (FDA). ... Patients at high risk of relapse are eligible for InPACT-pelvis, where they are randomised to either: ...

4. Mayo Clinic Trauma Professionals Update - June 2025

   Page 1.

5. 血液科- 临床试验- 妙佑医疗国际

   ... approved by the U.S. Food and Drug Administration (FDA). ... Patients at high risk of relapse are eligible for InPACT-pelvis, where they are randomised to either: ...

6. 血液科- 临床试验- 妙佑医疗国际

   ... approved by the U.S. Food and Drug Administration (FDA). ... Patients at high risk of relapse are eligible for InPACT-pelvis, where they are randomised to either: ...

7. 外科 - 临床试验- 妙佑医疗国际

   The purpose of this study is to determine whether off-pump bilateral orthotopic lung transplantation (BOLT) or venoarterial extracorporeal membrane ...

8. Living-donor appointment request

   Numbers and special characters are not allowed. Legal middle name ... Even if you are approved, you can change your mind at any time. If you want ...

9. 妙佑医疗国际 - 资格

   1 型糖尿病的患者通常是胰腺移植的候选者。2 型糖尿病患者和在胰腺切除术后罹患糖尿病的患者可能符合胰腺移植的资格。 您的移植团队将对您进行评估，以确定胰腺移植 ...

10. 血液科- 临床试验- 妙佑医疗国际

    ... approved by the U.S. Food and Drug Administration (FDA). ... Patients at high risk of relapse are eligible for InPACT-pelvis, where they are randomised to either: ...